4586 — Medrx Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥5bn
- ¥4bn
- ¥30m
Annual cashflow statement for Medrx Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,611 | -1,107 | -1,058 | -1,109 | -930 |
| Depreciation | |||||
| Non-Cash Items | -21.7 | -37 | -5.97 | 3.47 | 1.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 46 | 102 | 80.4 | -13.9 | -30.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,547 | -985 | -924 | -1,073 | -914 |
| Capital Expenditures | -253 | -39.4 | -2.54 | -1.96 | -0.759 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.22 | 34.3 | — | — | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -252 | -5.1 | -2.54 | -1.96 | -0.759 |
| Financing Cash Flow Items | 2.45 | 6.31 | 14.9 | 4.18 | 1.75 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,415 | 1,394 | 816 | 356 | 1,639 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -386 | 402 | -109 | -710 | 727 |